EXPRESSION OF CD56, CK19 AND HBME-1 IN FOLLICULAR VARIANT OF PAPILLARY THYROID CARCINOMA AND BENIGN MIMICKERS

Authors

  • Hassan Tariq Armed Forces Institute of Pathology (National University of Medical Sciences) Rawalpindi Pakistan
  • Amna Iqbal Federal Medical and Dental College, Islamabad Pakistan
  • Hafeez Ud Din Armed Forces Institute of Pathology (National University of Medical Sciences) Rawalpindi Pakistan
  • Syed Raza Jaffar Armed Forces Institute of Pathology (National University of Medical Sciences) Rawalpindi Pakistan
  • Sardar Waleed Babar Armed Forces Institute of Pathology (National University of Medical Sciences) Rawalpindi Pakistan
  • Asma Gul Armed Forces Institute of Pathology (National University of Medical Sciences) Rawalpindi Pakistan

Abstract

Objective: To assess the diagnostic utility of a set of 3 markers i.e. CD56, CK-19 and HBME-1 to differentiate follicular variant of papillary carcinoma (FVPC) from its benign mimickers.

Material and Methods: This is a prospective cross-sectional study conducted at Histopathology department of Armed force institute of pathology (AFIP) Rawalpindi, Pakistan from May 2020 to Aug 2020. A cross-sectional study in which samples of 40 thyroid lesions that included 20 FVPTC and 20 hyperplasia/adenomas were retrieved from the database of the Department of Histopathology of Armed Forces Institute of Pathology, Rawalpindi. Immunohistochemistry was done to assess the expression of CD56, CK19 and HBME-1 in FVPTC (n=20) and hyperplasia/adenoma (n=20). Results were analyzed using SPSS 21.

Results: Strongly positive (2+) staining with CK19 and HBME-1 was observed in 95% and 80% of the FVPTC patients respectively. Expression of CD56 was negative in 80% of FVPTC. A significant statistical difference was observed in the expression of HBME-1, CK19 and CD56 in FVPTC and benign lesions (P<0.05).

Conclusion: Negative staining for CD56 in a thyroid lesion while at the same time co-expression of diffuse and strong staining with CK19 and HBME-1 in a follicular pattern lesion posing a diagnostic challenge is highly suggestive of FVPTC provided it is interpreted in the right context.

Key Words: Immunohistochemistry, CD56, HBME-1, CK19, Follicular variant of papillary carcinoma.

Downloads

Published

26-03-2021

How to Cite

1.
Tariq H, Iqbal A, Din HU, Jaffar SR, Babar SW, Gul A. EXPRESSION OF CD56, CK19 AND HBME-1 IN FOLLICULAR VARIANT OF PAPILLARY THYROID CARCINOMA AND BENIGN MIMICKERS. Pak J Pathol [Internet]. 2021 Mar. 26 [cited 2026 Oct. 28];32(1):1-4. Available from: https://pakjpath.com/index.php/Pak-J-Pathol/article/view/604

Issue

Vol. 32 No. 1 (2021): Pakistan Journal of Pathology

Section

Articles

License

Copyright (c) 2021 Hassan Tariq, Amna Iqbal, Hafeez Ud Din, Syed Raza Jaffar, Sardar Waleed Babar, Asma Gul

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.